Table II.
A, Prediction of different pathological subtypes | ||||||
---|---|---|---|---|---|---|
| ||||||
First author, year | Disease | Number of patients | AI model | Main result | Main conclusion | (Refs.) |
Farahani et al, 2022 | OC | 545 | ML | The best-performing model achieved a diagnostic concordance of 81.38% (Cohen's κ, 0.7378) in the training set and 80.97% concordance (Cohen's κ, 0.7547) in the external dataset. | The CNN model may improve the diagnostic efficiency for determining OC pathological subtypes. | (96) |
Wang et al, 2022 | OC | 288 | DL | For an independent testing set, the three proposed methods obtained promising results with high recall (sensitivity) values of 0.946, 0.893 and 0.964, respectively. | The DL method can help identify patients with different treatment responses. | (97) |
| ||||||
B, Predict the mutation status of a gene | ||||||
| ||||||
First author, year | Disease | Number of patients | AI model | Main result | Main conclusion | (Refs.) |
| ||||||
Ho et al, 2023 | OC | 609 | DL | The model achieved an intersection-over-union value of 0.74, a recall value of 0.86 and a precision value of 0.84. | The DL model can be used to diagnose OC and find novel morphological patterns to predict molecular subtypes. | (98) |
Nero et al, 2022 | HGSOC | 644 | DL | The model achieved an AUC of 0.71, with a negative predictive value of 0.69 and a positive predictive value of 0.75 when applied to predict PFS. | The DL model based on WSI can predict BRCA1/2 gene status. | (99) |
| ||||||
C, Predict the efficacy and prognosis of drug therapy | ||||||
| ||||||
First author, year | Disease | Number of patients | AI model | Main result | Main conclusion | (Refs.) |
| ||||||
Laury et al, 2021 | HGSOC | 30 | CNN | The CNN model based on WSI discriminated the response to primary platinum-based chemotherapy with high sensitivity (73%) and specificity (91%). | DL based image analysis is able to. predict outcome | (100) |
Wang et al, 2022 | EOC | 720 | DL | The model in combination with AIM2 achieves high accuracy (0.92), recall (0.97), F-measure (0.93) and AUC (0.97) values for the first experiment (66% training and 34% testing) and high accuracy (0.86±0.07), precision (0.9±0.07), recall (0.85±0.06), F-measure (0.87±0.06) and AUC (0.91±0.05) for the second experiment using five-fold cross validation, respectively. | AIM2-DL model can distinguish patients gaining positive therapeutic effects with low cancer recurrence from patients with disease progression after treatment. | (102) |
Wu et al, 2022 | OC | 90 | DL | The mean value of the resulting C-index was 0.5789 (range, 0.5096-0.6053), and the resulting P-value was 0.00845. | The DL framework is a promising method for searching WSIs and providing a valuable clinical means for prognosis. | (103) |
AI, artificial intelligence; OC, ovarian cancer; EOC, epithelial ovarian cancer; HGSOC, high-grade serous ovarian cancer; ML, machine learning; DL, deep learning; CNN, convolutional neural network; AUC, area under the curve; PFS, progression-free survival; WSI, whole slide imaging.